Evaluation of the Pupil Dilation Reflex in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial
NCT ID: NCT03449732
Last Updated: 2022-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-03-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital
NCT06832046
Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL
NCT03485014
Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: Trial
NCT02947243
Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL
NCT03682302
Methoxyflurane Analgesia for Paediatric Injuries
NCT03215056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PDR measurement group A
Two measurements of PDR perioperatively before and after opioid administration in toddlers (28 days until 23 months)
PDR measurement
PDR measurement at two standardized times perioperatively:
1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth
PDR measurement group B
Two measurements of PDR perioperatively before and after opioid administration in children (2 until 11 years)
PDR measurement
PDR measurement at two standardized times perioperatively:
1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth
PDR measurement group C
Two measurements of PDR perioperatively before and after opioid administration in adolescents (12 until 18 years)
PDR measurement
PDR measurement at two standardized times perioperatively:
1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PDR measurement
PDR measurement at two standardized times perioperatively:
1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-II
Exclusion Criteria
* Known cranial nerve(s) deficit
* Infection of the eye
* Predicted difficult airway management (Paediatric Difficult Airway Guidelines - Difficult Airway Society)
* Chronic opioid use (\>3 months)
* Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine
* Preoperatively administrated benzodiazepins or antiemetics
28 Days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davina Wildemeersch
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Kegels, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Antwerp
Vera Saldien, MD
Role: STUDY_CHAIR
University Hospital, Antwerp
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Antwerp
Edegem, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/46/519
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.